US Bancorp’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,296
| Closed | -$183K | – | 4135 |
|
|
2021
Q1 | $183K | Sell |
2,296
-4,561
| -67% | -$356K | ﹤0.01% | 1963 |
|
|
2020
Q4 | $541K | Buy |
6,857
+242
| +4% | +$14.2K | ﹤0.01% | 1396 |
|
|
2020
Q3 | $290K | Sell |
6,615
-701
| -10% | -$34.5K | ﹤0.01% | 1602 |
|
|
2020
Q2 | $324K | Sell |
7,316
-4,164
| -36% | -$155K | ﹤0.01% | 1529 |
|
|
2020
Q1 | $412K | Sell |
11,480
-845
| -7% | -$48K | ﹤0.01% | 1304 |
|
|
2019
Q4 | $874K | Sell |
12,325
-3,232
| -21% | -$234K | ﹤0.01% | 1108 |
|
|
2019
Q3 | $1.17M | Buy |
15,557
+2,749
| +21% | +$233K | ﹤0.01% | 968 |
|
|
2019
Q2 | $1.03M | Buy |
12,808
+5,589
| +77% | +$393K | ﹤0.01% | 1061 |
|
|
2019
Q1 | $482K | Buy |
7,219
+3,370
| +88% | +$255K | ﹤0.01% | 1399 |
|
|
2018
Q4 | $287K | Buy |
3,849
+447
| +13% | +$36.9K | ﹤0.01% | 1592 |
|
|
2018
Q3 | $314K | Buy |
3,402
+229
| +7% | +$21.8K | ﹤0.01% | 1638 |
|
|
2018
Q2 | $312K | Sell |
3,173
-10
| -0.3% | -$1.12K | ﹤0.01% | 1649 |
|
|
2018
Q1 | $355K | Buy |
3,183
+7
| +0.2% | +$785 | ﹤0.01% | 1592 |
|
|
2017
Q4 | $327K | Sell |
3,176
-269
| -8% | -$26.8K | ﹤0.01% | 1624 |
|
|
2017
Q3 | $325K | Buy |
3,445
+245
| +8% | +$19.3K | ﹤0.01% | 1627 |
|
|
2017
Q2 | $249K | Buy |
3,200
+92
| +3% | +$6.91K | ﹤0.01% | 1735 |
|
|
2017
Q1 | $249K | Buy |
3,108
+19
| +0.6% | +$1.51K | ﹤0.01% | 1713 |
|
|
2016
Q4 | $243K | Buy |
3,089
+1,939
| +169% | +$151K | ﹤0.01% | 1708 |
|
|
2016
Q3 | $90K | Hold |
1,150
| – | – | ﹤0.01% | 2151 |
|
|
2016
Q2 | $79K | Sell |
1,150
-66
| -5% | -$4.55K | ﹤0.01% | 2183 |
|
|
2016
Q1 | $87K | Sell |
1,216
-58
| -5% | -$3.64K | ﹤0.01% | 2092 |
|
|
2015
Q4 | $80K | Buy |
1,274
+244
| +24% | +$14.9K | ﹤0.01% | 2200 |
|
|
2015
Q3 | $58K | Hold |
1,030
| – | – | ﹤0.01% | 2382 |
|
|
2015
Q2 | $55K | Sell |
1,030
-742
| -42% | -$36.1K | ﹤0.01% | 2480 |
|
|
2015
Q1 | $84K | Sell |
1,772
-846
| -32% | -$37.4K | ﹤0.01% | 2264 |
|
|
2014
Q4 | $114K | Sell |
2,618
-110
| -4% | -$4.49K | ﹤0.01% | 2067 |
|
|
2014
Q3 | $94K | Buy |
2,728
+40
| +1% | +$1.41K | ﹤0.01% | 2139 |
|
|
2014
Q2 | $99K | Sell |
2,688
-1,820
| -40% | -$61.7K | ﹤0.01% | 2142 |
|
|
2014
Q1 | $152K | Sell |
4,508
-1,357
| -23% | -$44.8K | ﹤0.01% | 1909 |
|
|
2013
Q4 | $199K | Sell |
5,865
-101
| -2% | -$3.5K | ﹤0.01% | 1732 |
|
|
2013
Q3 | $190K | Sell |
5,966
-565
| -9% | -$15K | ﹤0.01% | 1708 |
|
|
2013
Q2 | $147K | Buy |
+6,531
| New | +$141K | ﹤0.01% | 1802 |
|
US Bancorp's CMD Position: Q2 2021 in Review
US Bancorp sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 2,296 shares — an estimated $183K sold.
US Bancorp first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $1.17M in Q3 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- US Bancorp reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- US Bancorp sold 2,296 Cantel Medical Corporation shares in Q2 2021, an estimated $183K.
- US Bancorp first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- US Bancorp's Cantel Medical Corporation position peaked at $1.17M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.